New Lymphoma Drug SGN-35 – The Nebraska Medical Center

Posted: Published on October 4th, 2011

This post was added by Dr P. Richardson



"This is really a breakthrough in that we finally have something to treat these really difficult to treat patients." The FDA approved SGN-35 as a treatment for Hodgkin's Lymphoma in August 2011. It is the first FDA-approved Hodgkin's treatment since 1977

See the original post:
New Lymphoma Drug SGN-35 - The Nebraska Medical Center

Related Posts
This entry was posted in Cell Medicine. Bookmark the permalink.

Comments are closed.